9.31
Schlusskurs vom Vortag:
$8.42
Offen:
$8.66
24-Stunden-Volumen:
24,599
Relative Volume:
0.80
Marktkapitalisierung:
$25.94M
Einnahmen:
$6.56M
Nettoeinkommen (Verlust:
$-14.92M
KGV:
-17.24
EPS:
-0.54
Netto-Cashflow:
$-33.87M
1W Leistung:
+16.08%
1M Leistung:
+28.96%
6M Leistung:
+3.56%
1J Leistung:
+17.85%
Sol Gel Technologies Ltd Stock (SLGL) Company Profile
Firmenname
Sol Gel Technologies Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie SLGL mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
SLGL
Sol Gel Technologies Ltd
|
9.31 | 22.34M | 6.56M | -14.92M | -33.87M | -0.54 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Sol Gel Technologies Ltd Stock (SLGL) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-08-19 | Herabstufung | Raymond James | Strong Buy → Outperform |
2022-10-21 | Fortgesetzt | Jefferies | Hold |
2019-12-31 | Bestätigt | H.C. Wainwright | Buy |
2019-12-31 | Bestätigt | JMP Securities | Mkt Outperform |
Sol Gel Technologies Ltd Aktie (SLGL) Neueste Nachrichten
What drives Sol Gel Technologies Ltd. stock priceUnprecedented growth rates - jammulinksnews.com
Sol Gel Technologies Ltd. Stock Analysis and ForecastFree Consultation - jammulinksnews.com
Top Stocks for Portfolio Rebalancing Expert Stock ForecastsBreakout stock performance - Autocar Professional
Is Sol Gel Technologies Ltd. a good long term investmentTremendous financial leverage - jammulinksnews.com
ArcBest Corporation Stock Analysis and ForecastStrong return on assets - jammulinksnews.com
What analysts say about Sol Gel Technologies Ltd. stockFree Stock Market Mentorship - jammulinksnews.com
Sol-Gel Technologies (NASDAQ:SLGL) and Supernus Pharmaceuticals (NASDAQ:SUPN) Head-To-Head Survey - Defense World
Protalix BioTherapeutics Appoints Gilad Mamlok as its New Senior Vice President and Chief Financial Officer - StreetInsider
Best FMCG Stocks Successful Trader RecommendationsExceptional profit potential - printweek.in
What analysts say about Sixth Street Specialty Lending Inc. stockHigh-yield portfolio picks - PrintWeekIndia
Subros Limited (517168) Signs Major DealOutstanding capital returns - jammulinksnews.com
What analysts say about Jiayin Group Inc. Depositary Receipt stockPowerful profit generation - Jammu Links News
BNX(binaryx) Project ReviewFree Popular Stock Recommendations - Newser
What drives Junee Limited stock priceStrong return on assets - jammulinksnews.com
The Future of Renewable Energy Stocks in India Market Trend ForecastingDynamic investment growth - Jammu Links News
Will Noah Holdings Limited Depositary Receipt stock benefit from interest rate changesInvestor Favorite Picks - Newser
What makes Sol Gel Technologies Ltd. stock price move sharplyFree VIP Group - beatles.ru
TSD(truedollarfinance)Capital Efficient Investment Tips - Newser
What makes Millrose Properties Inc. stock price move sharplyExplosive Growth Potential - Newser
Why CTRA stock attracts strong analyst attentionEntry Level Low Risk Picks - Newser
How YUMC stock performs during market volatilityFast Gains With Reduced Risk - Newser
Why Sol Gel Technologies Ltd. stock attracts strong analyst attentionFree Growth Investment Group - Newser
What makes Lifeward Ltd. stock price move sharplyFree Predictions - Newser
How Sol Gel Technologies Ltd. stock performs during market volatilityPro Trader Stock Focus - Newser
Sol-Gel Technologies (NASDAQ:SLGL) Shares Down 0.1% – What’s Next? - Defense World
(PDF) Synthesis and Characterization of CZTS Thin Films by Sol-Gel Method without Sulfurization - researchgate.net
Sol-Gel (SLGL) Projects Cash Resources to Sustain Through Q1 202 - GuruFocus
Sol-Gel Technologies Reports Q1 2025 Financial Results - TipRanks
Sol-Gel Stock Tumbles Over Underwhelming Q1 Earnings: Retail Stays Pessimistic By Stocktwits - Investing.com India
Sol-Gel Technologies Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
SLGL Boosts Q1 Revenue to $1 Million, Doubling Last Year's Perfo - GuruFocus
Sol-Gel (SLGL) Projects Cash Resources to Sustain Through Q1 2027 | SLGL Stock News - GuruFocus
Sol-Gel Reports First Quarter 2025 Results - Stock Titan
Sol-Gel Reports First Quarter 2025 Results | SLGL Stock News - GuruFocus
Sol-Gel Technologies Reports Q1 2025 Financial Results and Increased R&D Expenses - Nasdaq
Actinic Keratosis Drugs Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Prevalence, Medication, Therapies, NICE Approvals and Companies by DelveInsight - The Globe and Mail
Finanzdaten der Sol Gel Technologies Ltd-Aktie (SLGL)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):